Endocrine Therapy in Breast Cancer
-
10% KEDVEZMÉNY?
- A kedvezmény csak az 'Értesítés a kedvenc témákról' hírlevelünk címzettjeinek rendeléseire érvényes.
- Kiadói listaár GBP 107.00
-
51 119 Ft (48 685 Ft + 5% áfa)
Az ár azért becsült, mert a rendelés pillanatában nem lehet pontosan tudni, hogy a beérkezéskor milyen lesz a forint árfolyama az adott termék eredeti devizájához képest. Ha a forint romlana, kissé többet, ha javulna, kissé kevesebbet kell majd fizetnie.
- Kedvezmény(ek) 10% (cc. 5 112 Ft off)
- Kedvezményes ár 46 007 Ft (43 817 Ft + 5% áfa)
Iratkozzon fel most és részesüljön kedvezőbb árainkból!
Feliratkozom
51 119 Ft
Beszerezhetőség
A kiadónál véglegesen elfogyott, nem rendelhető. Érdemes újra keresni a címmel, hátha van újabb kiadás.
Why don't you give exact delivery time?
A beszerzés időigényét az eddigi tapasztalatokra alapozva adjuk meg. Azért becsült, mert a terméket külföldről hozzuk be, így a kiadó kiszolgálásának pillanatnyi gyorsaságától is függ. A megadottnál gyorsabb és lassabb szállítás is elképzelhető, de mindent megteszünk, hogy Ön a lehető leghamarabb jusson hozzá a termékhez.
A termék adatai:
- Kiadás sorszáma 1
- Kiadó CRC Press
- Megjelenés dátuma 2002. március 8.
- ISBN 9780824707873
- Kötéstípus Keménykötés
- Terjedelem400 oldal
- Méret 254x177 mm
- Súly 658 g
- Nyelv angol 0
Kategóriák
Rövid leírás:
Jan G. M. Klijn, Els M. J. J. Berns, and John A. Foekens
Panel Discussion 1: Advanced Breast Cancer
Manfred Kaufmann and Henning T. Mouridsen
Early Breast Cancer
Early Breast Cancer: Tamoxifen Overview
Carsten Rose
Aromatase Inhibitors and Early Breast Cancer
Paul E. Goss
SERMs: Overview in Early Breast Cancer
Ian E. Smith
Surrogate and Intermediate Markers in Early Breast Cancer
Mitch Dowsett
Panel Discussion 2: Early Breast Cancer
Hans-Jorg Senn and William R. Miller
Neoadjuvant Therapy
Neoadjuvant Endocrine Therapy for Breast Cancer: A Medical Oncologist's Perspective
Matthew J. Ellis
Neoadjuvant Therapy: Surgical Perspectives
J. Michael Dixon
Pathology of Breast Cancer Following Neoadjuvant Endocrine Therapy
Hironobu Sasano, Takashi Suzuki, and Takuya Moriya
Neoadjuvant Therapy: Prediction of Response
William R. Miller, T. J. Anderson, S. Iqbal, and J. Michael Dixon
Mechanisms of Resistance to Endocrine Therapy
Nancy E. Hynes
Panel Discussion 3: Neoadjuvant Therapy
James N. Ingle and Ian E. Smith
Chemoprevention
Epidemiological Basis of Hormonal Chemoprevention of Breast Cancer
Malcolm C. Pike, John R. Daniels, and Darcy V. Spicer
Breast Carcinogenesis and Its Prevention by Inhibition of Estrogen Genotoxicity
Joachim G. Liehr
Use of Selective Antiestrogens for the Chemoprevention of Breast Cancer
Trevor J. Powles
Aromatase Inhibitors and Chemoprevention of Breast Cancer
Paul E. Goss
Panel Discussion 4: Chemoprevention
Christopher C. Benz and Anthony Howell
Conclusion
Panel Discussion 5: Final Discussion and Wrap-Up
James N. Ingle and Ajay Bhatnagar
Index
This reference evaluates and describes the latest strategies for hormone suppression and blockade in the management of early and advanced stage breast cancer and explores the effects of tamoxifen, selective estrogen receptor modulators (SERMs), aromatase inhibitors, and their combination on both breast cancers and normal tissues.
Endocrine Therapy in Breast Cancer
Surveying the medical, surgical, and pathological aspects of endocrine therapy, as well as future research opportunities, Endocrine Therapy in Breast Cancer is a concise and in-depth manual for medical, surgical, and radiation oncologists; endocrinologists; gynecologists; obstetricians; pharmacologists; family physicians; reproductive biologists; epidemiologists; and medical school students.
Hosszú leírás:
This reference evaluates and describes the latest strategies for hormone suppression and blockade in the management of early and advanced stage breast cancer and explores the effects of tamoxifen, selective estrogen receptor modulators (SERMs), aromatase inhibitors, and their combination on both breast cancers and normal tissues.
Endocrine Therapy in Breast Cancer
Surveying the medical, surgical, and pathological aspects of endocrine therapy, as well as future research opportunities, Endocrine Therapy in Breast Cancer is a concise and in-depth manual for medical, surgical, and radiation oncologists; endocrinologists; gynecologists; obstetricians; pharmacologists; family physicians; reproductive biologists; epidemiologists; and medical school students.
This reference evaluates and describes the latest strategies for hormone suppression and blockade in the management of early and advanced stage breast cancer and explores the effects of tamoxifen, selective estrogen receptor modulators (SERMs), aromatase inhibitors, and their combination on both breast cancers and normal tissues.
Endocrine Therapy in Breast Cancer
Surveying the medical, surgical, and pathological aspects of endocrine therapy, as well as future research opportunities, Endocrine Therapy in Breast Cancer is a concise and in-depth manual for medical, surgical, and radiation oncologists; endocrinologists; gynecologists; obstetricians; pharmacologists; family physicians; reproductive biologists; epidemiologists; and medical school students.
Tartalomjegyzék:
Introduction
Why Endocrine Therapy?
Daniel F. Hayes
Advanced Breast Cancer
Tamoxifen and Advanced Breast Cancer: An Overview
John F. Forbes
Overview of Aromatase Inhibitors and Inactivators in the Treatment of Advanced Breast Cancer
Per Eystein Lonning
Endocrine Treatment of Advanced Breast Cancer-Selective Estrogen-Receptor Modulators (SERMs)
Stephen R. D. Johnston and Anthony Howell
Other Endocrine and Biological Agents in the Treatment of Advanced Breast Cancer
